The European Commission (DG CONNECT) will be holding a webinar on 29 January from 11.00 to 12.00 CET on the call topic "Internet of Things: IoT-01-2016: Large Scale Pilots Pilot 1: Smart living environments for ageing well". The webinar will give an overview of the topic and provide answers to participants' questions via the chatroom. If you want to participate, please send an e-mail to CNECT-ICT4AGEING@ec.europa.eu, subject: webinar registration. Proposers should also check the networking tool.
EU-funding helped scholar Christophe Fricker restart his academic career and link it up with his experiences in the business world. His research has shed new light on the life and writing of controversial German author Ernst Junger.
Poorly managed resource extraction can have a considerably negative impact on the environment, in particular on drinking water, and on individuals and societies. An EU-funded STRADE project will examine how can the sustainable supply of raw materials for the European Union be secured and sustainably exploited as well as how can the European Union successfully work together with developing countries on an international level.
New technologies claiming to protect pedestrians and cyclists in the event of a collision are being developed all the time. They could reduce pedestrian fatalities by 15-20%. But how do we know which systems are effective? How can we compare them? An EU-funded project drew up harmonised test and assessment procedures for pedestrian safety systems.
Despite enormous progress in the prevention and treatment of HIV/AIDS, the global response cannot keep pace: 35 million people are living with HIV worldwide with around 6,000 new infections each day. Numerous HIV prevention strategies, though proven successful, are difficult to sustain long-term. A vaccine still represents the most effective tool in the combat against HIV from a public health perspective.
The development of innovative treatments for infectious diseases such as hepatitis B and tuberculosis as well as for human papillomavirus-induced cancer will get a boost thanks to a new €20 million loan to French biopharmaceutical company Transgene SA, provided by the InnovFin Infectious Diseases (ID) facility.
Small and medium-sized enterprises (SMEs) in seven countries in South-eastern Europe – Albania, Bosnia and Herzegovina, Bulgaria, The Former Yugoslav Republic of Macedonia, Moldova, Romania and Serbia - will get easier access to risk capital.